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http:WHAT THIS PAPER ADDS
Characteristics of the carotid plaque in patients with carotid stensosis can identify those patients with relatively
higher risk for stroke and help select patients who may beneﬁt from intervention over medical treatment alone
or vice versa. This review discusses the current role of two-dimensional and three-dimensional ultrasound,
computed tomography, magnetic resonance imaging, and positron emission tomography in deﬁning carotid
plaque characteristics and in informing clinical practice. Most of these non-invasive imaging techniques have
been discussed as single entity techniques. This paper puts the relative strengths and weaknesses of the
different technical options in perspective in relation to clinical applicability.Background: The current clinical practise to determine if a patient should undergo carotid intervention to
prevent stroke is to determine the clinical features combined with degree of carotid stenosis. However, this does
not accurately determine the individual patient’s risk for future stroke. A thin ﬁbrous cap, a large lipid core, high
macrophage count, and intraplaque haemorrhage have all been identiﬁed as markers of the so-called
“vulnerable” plaque being related to a higher stroke risk. There is a need to assess the accuracy of in vivo imaging
to identify vulnerable plaque characteristics, thereby enabling in vivo risk stratiﬁcation to guide clinical decision-
making.
Methods: The aim of this topical review is to assess the roles of currently available imaging modalities that are
applied in clinical practice and those experimental techniques that are close to clinical translation in deﬁning
carotid plaque characteristics and in informing clinical practice.
Results: Ultrasound is a low cost and ready available low-risk tool, but it lacks the accuracy to reliably detect
individual plaque components and characteristics. Computed tomography is considered to be the best imaging
technique to identify calciﬁcation in the carotid plaque. Magnetic resonance imaging (MRI) can identify most
described plaque characteristics with moderate to good agreement. Positron emission tomography allows
assessment of speciﬁc metabolic functions with tracers labelled with positron emitting radio-isotopes, but limited
spatial resolution makes anatomic precision imprecise.
Conclusion: MRI has demonstrated the most potential, with good sensitivity and speciﬁcity for most plaque
characteristics. However, currently there is no single imaging modality that can reliably identify the vulnerable
plaque in relation to development of future stroke.
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Cerebral embolism from atherosclerotic carotid plaque re-
mains an important pathophysiological mechanism of ipsi-
lateral stroke, and carotid endarterectomy (CEA) in recently
Table 1. Non-invasive carotid imaging techniques and relevant
needs for the future.
Techniques Relevant needs for the future
Ultrasound (US) 3D ultrasound
Contrast-enhanced ultrasound (CEUS)
Computed
tomography (CT)
Automated removal of bone pixels
Thin slice reconstructions
3D lumen geometry and shear stress
Magnetic resonance
imaging (MRI)
3D SNAP protocol
7-Tesla MRI
Automated segmentation techniques
Position emission
tomography (PET)
Development of new tracers
Coregistration PET/CT and PET/MRI
564 A. Huibers et al.symptomatic patients with a high-grade carotid artery ste-
nosis signiﬁcantly reduces the (recurrent) stroke risk.
The principle indication for carotid revascularisation is
based on symptomatic status, timing, and degree of ipsi-
lateral carotid artery stenosis. In symptomatic patients, with
for example a single ocular symptom and smooth 70% ca-
rotid stenosis, the risk for recurrent stroke may be very low,
and in these patients the beneﬁt of revascularisation may
be marginal. Alternatively, in asymptomatic patients the
indication for revascularisation still remains a matter of
debate, and current UK guidelines generally advocate a
conservative approach in these patients, unless part of a
clinical trial.1 Overall in asymptomatic males, younger than
75 years, CEA compared with best medical treatment (BMT)
signiﬁcantly reduces the 10-year stroke risk.2 However,
based on clinical patient characteristics, selected subgroups
of patients with asymptomatic carotid stenosis may beneﬁt
from carotid revascularisation. Increased systolic blood
pressure, raised serum creatinine, smoking history, and a
history of contralateral transient ischaemic attacks have
been associated with an increased natural risk of ipsilateral
cerebrovascular or retinal ischemic events.3 However, these
parameters are insufﬁcient to fully balance the natural risk
with procedural risk and additional anatomical and vessel
wall-speciﬁc parameters are needed to ultimately assess the
individual patient risk for future stroke and related beneﬁt
of revascularisation.
Research in carotid imaging has focused on identifying
characteristics that determine the “vulnerable” or unstable
carotid plaque making the patient at “high risk for future
ipsilateral stroke”.4,5 Several structural plaque characteris-
tics are proposed that distinguish the “vulnerable” from the
“non-vulnerable” plaque, which includes plaque ulceration,
intraplaque haemorrhage (IPH), thin or ruptured ﬁbrous cap
(FC), lipid-rich necrotic core, and the presence of calciﬁca-
tion.6 Inﬂammation may also play a role in the development
and progression of disease as well as identifying the
vulnerable plaque.7 A limitation of these studies on histo-
logical validation is the basis on post-endarterectomy
specimens, and that they are mostly derived from symp-
tomatic patients, with a relative long time interval between
index event and CEA.8
Identifying features of the vulnerable plaque in vivo may
help select patients who beneﬁt from intervention over
medical treatment alone or vice versa. A variety of con-
ventional and advanced in vivo imaging modalities including
two-dimensional (2D) or three-dimensional (3D) ultrasound
(US), computed tomography (CT), high-resolution magnetic
resonance imaging (HRMRI), and nuclear imaging tech-
niques such as positron emission tomography (PET) have
been applied to identify plaque characteristics. Each tech-
nique and modality has been applied in observational
studies to identify features of the carotid plaque, but it is
unclear whether these newer techniques can be translated
to, and impact on, daily clinical care, leading ultimately to
patient beneﬁt.
This paper overviews the literature on currently available
non-invasive imaging techniques to characterise thevulnerable carotid plaque with histology as the gold stan-
dard, and summarises the challenges and needs for the
development of next-generation imaging tools to be of help
in future clinical decision-making (Tables 1 and 2).
ULTRASOUND
Current state
US is the modality of choice for initial evaluation and
conﬁrmation of carotid artery disease. US is used with high-
resolution B-mode imaging alone or in combination with
colour Doppler ﬂow. US is a widely available, low cost and
low-risk tool, which is well tolerated by patients and thus
ideal for screening for the presence of the atherosclerotic
plaque. A disadvantage is that it relies on the operator’s
ability, and systemic haemodynamic and local anatomic
factors, such as calciﬁcation and tortuosity of the carotid
artery. Variable levels of interobserver agreement for Inter-
nal Carotid Artery Peak Systolic Velocity (ICA PSV) ranging
from25% to 43% between experienced technologists have
been reported.9 However, in the UK the Society of Vascular
Technologists promote internal audit with duplicate scan-
ning between technicians to standardise reporting.
The use of the grey-scale median (GSM), a computerised
measurement of plaque echogenicity, aims to differentiate
echogenic carotid plaques (associated with a ﬁbrocalciﬁed
content [stable appearance]) from echolucent plaques (with
a thin FC, a higher lipid or haemorrhagic content [unstable
appearance]). Although a low GSM, reﬂecting an echolucent
(unstable) lesion, has been associated with an increased risk
of cerebrovascular events,10 the use of different software
and different applications for GSM measurement between
research groups has resulted in a wide range of cut-off
values for the deﬁnition of vulnerable plaque with no
clear consensus or standardisation for routine practise.11
Ulceration
A focal depression, causing an irregular surface, suggests
plaque ulceration. The most widely used criteria to deﬁne
plaque ulceration are the presence of a recess of at least
2 mm deep and 2 mm long, a well-deﬁned wall at its base
and an area of reversed ﬂow at the level of the recess.12
Ultrasound may vary signiﬁcantly in sensitivity (33e75%)
and speciﬁcity (33e92%) for determining plaque ulceration
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looking for this feature.13,14Intraplaque haemorrhage
Haemorrhage can be found at the adventitial side of the
arterial wall as neovascularisation or intraluminal as a
thrombus, and incorporated in the plaque.15 Causality is
proposed by neovessel leakage or due to repeated plaque
ﬁssuring and formation of intraluminal thrombus that gets
incorporated into the plaque.16 Presence of thrombus or
intraplaque haemorrhage leads to an echolucent lesion on
US that is similar to a fatty core. Sensitivity and speciﬁcity
for detection of intraluminal thrombus using conventional
2D US are accurate in the range of 80e90% and 80e91%
respectively.17,18 This is in contrast to GSM ﬁndings and
intraplaque haemorrhage (IPH) histology (r ¼ .31 and
p ¼ .07).19
Neovascularisation itself can be detected by contrast-
enhanced US. Plaques with a higher contrast agent
enhancement showed a greater neovascularisation at his-
tology (grade 2 vs. grade 1 contrast enhancement: median
vasa vasorum density 3.24 mm2 vs. 1.82 mm2, respectively,
p ¼ .005).20Fibrous cap
The ﬁbrous cap (FC) appears as an echogenic structure that
displays stronger echoes than the overall plaque and blood.
Thickness of the FC can be determined with a 73% sensi-
tivity and 67% speciﬁcity using stratiﬁed GSM measure-
ments.21 Ultrasonic backscatter (IBS) was found to be lower
in the thin FC compared with the thick FC.22Lipid-rich core
Lipid appears echolucent and similar to IPH on ultrasound.
The presence of lipid necrosis contributes to a heteroge-
neous pattern of the plaque.23 The Asymptomatic Carotid
Stenosis and Risk of Stroke (ACSRS) study looked at the
overarching feature of “juxtaluminal black area” to account
for either IPH or a large fatty core, correlating this US
feature with increased risk of stroke in an observational
series.24 The size of the lipid core seems critical for the
stability of the plaque, the larger the pool the less stable the
plaque.25 Data on the ability to detect the lipid core are
conﬂicting, using ultrasound (r ¼ .58; p ¼ .031) or
computer-aided grey scale analysis (r ¼ .1; p ¼ .37).26,27Calciﬁcation
Calciﬁcation appears hyperechogenic and assessment has
been described by the mean pixel value,28 the GSM,10 and
the pixel distribution.26 All showed good correlation with
histology, respectively r ¼ .8, p ¼ .002; r ¼ .30, p ¼ .07, and
r ¼ .85, p ¼ .001. However, the studies were limited by a
small sample size. Furthermore, acoustic shadowing of a
heavily calciﬁed plaque limits the assessment of severity of
stenosis and other plaque characteristics.Discussion and future directions
Ultrasound is a low-cost, low-risk tool, and well-tolerated
by patients. However, it lacks the accuracy to reliably
detect individual plaque components and characteris-
tics.13,14,27 Speciﬁcally, IPH and a fatty core are both
ecolucent “black” areas. As is apparent from the above-
named studies, several problems can be addressed: in-
ter- and intraobserver variability, efﬁcacy of standardised
computerised assessments, and the limited assessment of
a heavily calciﬁed plaque due to acoustic shadowing.
Research efforts are ongoing to overcome these limita-
tions and to increase the clinical application of
ultrasound.
3D imaging may show improved reproducibility and al-
lows good visualisation of the luminal plaque surface and
would therefore be of use in the detection of plaque ul-
ceration. This technique detected carotid plaque ulceration
more frequently than the 2D method (16.1% vs. 6.5%
respectively).29 As 3D US can capture all critical dimensions
of the plaque, it has been used in volumetric measurements
of the carotid plaque, showing observer variability in the
range of 6e15%.30,31 Although 3D US seems promising, it
remains a research tool as solid state 3D probes are in
evolution and current techniques are time-consuming.
Furthermore, data on the accuracy of 3D ultrasound pla-
que characterisation with histological validation are
limited.29,32COMPUTED TOMOGRAPHY
Current state
CT angiography (CTA) is a validated tool for the non-
invasive assessment of degree of carotid artery stenosis.
Where ultrasound lacks the ability to image high bifurca-
tion and tortuous vessels, CTA is able to image from the
aortic arch to the brain parenchyma. However, the radia-
tion dosage, the need for intravenous contrast, and calci-
ﬁcation artefacts are acknowledged drawbacks. Hounsﬁeld
units (HU) are used to describe radiodensity on a quanti-
tive scale.Ulceration
The presence of a plaque ulcer on CTA is deﬁned as an
intimal defect with extension of contrast material beyond
the lumen into the surrounding plaque. The use of a mul-
tidetector CTA (MDCTA) detects ulceration with moderate
to good sensitivity (60e94%) and speciﬁcity (70e99%)
when compared with histology.14,33Intraplaque haemorrhage
IPH is associated with very low HU values (17 HU to 31
HU).32,33 MDCTA was able to detect plaques complicated
with haemorrhage with good sensitivity (100%) and mod-
erate to good speciﬁcity (64% and 70%).34,35 A further study
showed good correlation of CTA with histology for large
haemorrhages.36
Table 2. The correlation of non-invasive carotid imaging techniques with histology.
Year Patients Imaging Histology Sensitivity Speciﬁcity Correlation
Ultrasound e ulceration
Comerotaa 1990 109 Ulceration Ulceration 47% 84% NS
ECPSG 1995 270 Irregular plaque border Ulceration 47% 63% NS
Kardoulas 1996 36 Irregular plaque border Ulceration 64% 68% NS
Saba 2007 237 Ulceration Ulceration 38% 92% NS
Sitzer 1996 43 Ulceration
Ulceration/irregular
plaque border
Ulceration
Ulceration
33%
94%
76%
33%
NS
NS
Widder 1990 144 Irregular plaque border Ulceration 75% 64% NS
Ultrasound e intraplaque haemorrhage (IPH)
Aburahma 1998 111 Irregular plaque border IPH 81% 85% NS
Gronholdt 2001 38 Grey-scale median (GSM) % plaque haemorrhage NS NS r ¼ .31 (p ¼ .06)
Hatsukami 1994 24 Heterogenic and
echolucent
Haemorrhage 53% 76% NS
Kawasaki 2001 12 Backscatter index Thrombus 80% 91% NS
Lal 2006 42 PDA % plaque haemorrhage NS NS r ¼ .60 (p ¼ .001)
Noritomi 1997 15 Thrombus Thrombus 90% 80% NS
Widder 1990 144 Echolucent plaque IPH 34% 36% NS
Ultrasound e ﬁbrous cap (FC)
Sztajzel 2005 28 Low GSM values
dominant at plaque
surface
Thin FC 73% 67% NS
Ultrasound e lipid-rich core (LRC)
Lal 2006 42 Lipid core size Lipid core size NS NS r ¼ .58 (p ¼ .031)
Sztajzel 2005 28 Low GSM values
dominant at plaque
surface
Lipid core at luminal
surface
84% 75% NS
Tegos 2000 67 GSM Necrotic core size NS NS r ¼ .1 (p ¼ .37)
Ultrasound e calciﬁcation
Gronholdt 2001 38 GSM % plaque calciﬁcation NS NS r ¼ .30 (p ¼ .07)
Lal 2006 42 PDA % plaque calciﬁcation NS NS r ¼ .85 (p < .0001)
Computed tomography angiography (CTA) e ulceration
Oliver 1999 13 Irregular lumen Ulceration 50% 89% NS
Saba 2007 109 Ulceration VR þ axial Ulceration 94% 99% NS
Saba 2007 237 Ulceration Ulceration 94% 99% NS
Walker 2002 55 Ulceration Ulceration 60% 74% NS
Wintermark 2008 8 Ulceration Ulceration 87% 99% NS
CTA e IPH
Ajduk 2009 31 HU IPH 100% 64% NS
Ajduk 2013 50 HU IPH 100% 74% NS
Gronholdt 2001 38 HU % plaque haemorrhage NS NS r ¼ e .1 (p ¼ .57)
Oliver 1999 13 Hypodense Lipid/haemorrhage 94% 86% NS
Wintermark 2008 8 Large haemorrhage Large haemorrhage 62% 99% NS
CTA e FC
Wintermark 2008 8 HU FC thickness NS NS r2 ¼ .77 (p < .001)
CTA e LRC
De Weert 2006 15 HU Lipid core size
Lipid core size after
excluding calcium
NS NS r2 ¼ .24 (p < .001)
r2 ¼ .81 (p < .001)
Wintermark 2008 8 Lipid core Lipid core 76% 74% NS
CTA e calciﬁcation
Das 2009 30 HU Calciﬁed plaques NS NS r ¼ .95
Gronholdt 2001 38 HU % Calciﬁcation NS NS r ¼ .34 (p ¼ .04)
De Weert 2006 15 HU Calciﬁcation NS NS r2 ¼ .74 (p < .001)
Wintermark 2008 8 Large calciﬁcations Large calciﬁcations 100% 100% NS
Magnetic resonance imaging (MRI) e ulceration
Yu 2009 32 Ulceration Ulceration 80% 82% NS
MRI e IPH
Albuquerque 2007 42 IPH 96% 96% NS
Bitar 2008 8 IPH 97% 84% NS
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Table 2-continued
Year Patients Imaging Histology Sensitivity Speciﬁcity Correlation
Cai 2002 60 IPH type VI 82% 91% NS
Chu 2004 27 IPH 90% 74% NS
Moody 2003 63 IPH type VI 84% 84% NS
Puppini 2006 19 IPH alone 92% 100% NS
Qiao 2011 8 IPH 79% 87% NS
Saam 2005 40 IPH all areas
IPH areas > 2 mm2
82%
87%
77%
84%
NS
NS
MRI e FC
Cai 2002 60 FC type IV/V
FC type VI
84%
82%
90%
91%
NS
NS
Hatsukami 2000 22 FC rupture 89% 96% NS
Mitsumori 2003 18 Unstable FC 81% 90% NS
MRI e LRC
Cappendijk 2008 50 LRC single sequence
LRC multisequence
77e100%
82e100%
71e87%
69e86%
NS
NS
Yuan 2001 18 LRC alone 98% 100% NS
Saam 2005 40 LRC all areas
LRC all areas > 2 mm2
92%
95%
65%
76%
NS
NS
Puppini 2006 19 LRC alone 92% 95% NS
Young 2010 19 LRC 86% 40% NS
MRI e calciﬁcation
Cai 2002 60 Calciﬁcation Type VII 80% 94% NS
Saam 2005 40 Calciﬁcation all areas
Calciﬁcation
areas > 2 mm2
76%
84%
86%
91%
NS
NS
Puppini 2006 19 Calciﬁcation 80% 94% NS
PET e inﬂammation
Tawakol 2006 17 18F-FDG CD 68 NS NS r ¼ .7 (p < .0001)
Graebe 2009 10 18F-FDG CD 68 NS NS r ¼ .71 (p ¼ .02)
Menezes 2011 21 18F-FDG CD 68
MMP-9
NS
NS
NS
NS
r ¼ .71 (p ¼ .02)
a The complete reference citations from the table can be found in Appendix 1.
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An intact FC is believed to be associated with low-risk pla-
que rupture, whereas a thin or ﬁssured plaque is associated
with high-risk plaque rupture. FC thickness may be
measurable with a good correlation to histology,36 and
MDCTA observed an association between ﬁssured FC and
cerebrovascular symptoms.37 However this study did not
incorporate a histological analysis.
Lipid-rich core
A lipid core can be identiﬁable as hypodense region, with a
median tissue density ranging from 25 HU to 32.6 HU.36,38
In vivo MDCT may assess good correlations of a large lipid
core with histology. However, ﬁndings were limited to
mildly calciﬁed plaques.38
Calciﬁcation
CTA is a sensitive technique in the detection of calciﬁcation,
which appears as a high-density structure in the plaque. The
presence of calciﬁcation and quantiﬁcation of calciﬁcation
can be reliably detected with MDCT. A lower content of
calciﬁcation was associated with a greater prevalence of
neurological symptoms.39Discussion and future directions
CT is considered to be the best imaging technique to
identify calciﬁcation in the carotid plaque.39 However, sig-
niﬁcant overlap in HU values between different compo-
nents and the presence of calciﬁcation artefact limit its use
in plaque analysis. Removal of bone and calciﬁcation pixels
could potentially be a solution, but this is a time-consuming
process and therefore exceeds practical limits in routine
clinical work ﬂow. Therefore, a program for automated
removal of bone pixels from CTA data sets has been
proposed.40
In addition to plaque morphology and severity of ste-
nosis, MDCT has the ability to quantify plaque volume, with
a moderate interobserver variability.41 Furthermore, plaque
volume assessed by MDCT was correlated with severity of
stenosis and cardiovascular risk factors.42
There is increasing evidence that high shear stress plays
an important role in the enhancement of plaque vulnera-
bility.43 However, little is known about the exact patho-
physiological mechanism of shear stress in plaque
progression. MDCTA 3D lumen geometry assessment may
in the future contribute to the knowledge of various hae-
modynamic factors, such as sheared stress.44
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Current state
Because of its high soft-tissue contrast, high in-plane reso-
lution, and high reproducibility, MRI has shown great po-
tential in atherosclerotic plaque imaging with good
sensitivity and speciﬁcity. Several human in vivo studies
have shown the ability to detect vulnerable plaque char-
acteristics on 1.5-Tesla MRI, whereas the diagnostic accu-
racy of 3-Tesla and 7-Tesla MRI in patients with high-grade
stenosis is currently under investigation.45,46 Important
disadvantages of MRI include its relative low availability and
long procedure time. Furthermore, with the use of a clinical
1.5-Tesla scanner, it still remains a challenge to distinguish
different intraplaque tissues from each other because of an
inferior signal-to-noise ratio than scanners using a higher
ﬁeld magnet.Ulceration
MRI can detect ulceration with moderate sensitivity using
3D time-of-ﬂight (TOF), T1, proton density, T2, and contrast-
enhanced T1 sequences,47 where it appears as a surface
disruption on all contrast weightings. Adding longitudinal
black-blood MR angiography increases the sensitivity and
speciﬁcity of MRI to identify ulceration to 80% and 70%
respectively.48Intraplaque haemorrhage
MRI is of clinical value in detecting IPH and one of the most
investigated plaque components in MRI analysis. IPH can be
detected with a sensitivity of 82e97% and speciﬁcity of
74e100%.45,49 According to the age of thrombus, IPH ap-
pears hyperintense on T1-weigthed (T1W) and TOF images
and hypointense on T2-weigthed (T2W) and proton density
weighted images (fresh thrombus), hyperintense on all
contrast weightings (recent thrombus) or hypointense on all
contrast weightings (organised thrombus).50 It is hard to
distinguish IPH from a lipid-rich core (LRC) as the thrombus
is often located in the necrotic core.Fibrous cap
On MRI the FC appears as a juxtaluminal band, which is
hypointense at TOF weightings and isointense at T1, T2, and
proton density weightings. The absence of this band can
indicate either a ruptured or a thin FC. Differentiation be-
tween the last two still remains a signiﬁcant challenge.45
However, a 3D multiple overlapping thin slab protocol
may be capable of distinguishing the thick intact FC from
the intact thin and ruptured FC.50Lipid-rich core
An LRC can be detected on MRI with a sensitivity ranging
from 82% to 100% and a speciﬁcity ranging from 40% to
100%.49,51,52 On MRI, T1 sequences can identify an LRC,
where it appears as a hyperintense area. Detection of an
LRC slightly improves when IPH is not present.52Calciﬁcation
Calciﬁcation can be detected by MRI with a sensitivity of
76e84% and speciﬁcity of 86e94%. It appears hypointense
on all contrast images.45,49 Area measurement of calciﬁca-
tion as a percentage of the vessel wall may be under-
estimated using histology as the reference.51Discussion and future directions
Currently, MRI seems to have the most potential to identify
vulnerable plaque components, as it beneﬁts from high soft-
tissue contrast and a high in-plane resolution. The afore-
mentioned studies show that MRI can identify most
described plaque characteristics with moderate to good
agreement.45,48,49,51,52 Despite sufﬁcient evidence that MRI
can provide useful information on plaque characteristics,
there are potential barriers to its implementation as a
routine risk stratiﬁcation tool. Most importantly, its high cost
and low availability, especially for 3-Tesla and 7-Tesla MRI.
Recently a 3D-based MRI technique has been proposed.
This technique combines three 4-minute carotid plaque
sequences (3D SNAP, T1W pre- and post contrast) in a short
scanning time.53,54
Furthermore, there is a strong interest and ongoing
research in potential labelled biomarkers that target speciﬁc
molecules present in the “vulnerable” atherosclerotic
lesion. Molecular MRI can be performed using iron oxide
particles (USPIO) or other contrast agents that enhance
speciﬁc molecules or cells, such as elastin, ﬁbrin, or vascular
cell adhesion molecule-1 and are of potential in identifying
the “vulnerable” carotid plaque.55
As previous analyses revealed that patients with silent
cerebral ischaemic events are of high risk of future stroke,
another potential area for future research may focus on the
correlation between carotid plaque characteristics and ce-
rebral damage. Compared with 1.5-Tesla and 3-Tesla, 7-
Tesla MRI has proven to better visualise cerebral micro-
bleeds and micro-infarcts. In symptomatic patients with
high-grade stenosis, cerebral micro-infarcts detected by 7-
Tesla MRI were correlated with the total cerebrovascular
burden in the ipsilateral hemisphere.56
Currently, the atherosclerotic plaque features derived
from MRI wall imaging data are manually processed.
Consequently, this is subject to inter- and intra-observer
variability and an overall time-consuming process. Auto-
mated segmentation techniques have been developed to
overcome these drawbacks.44
POSITION EMISSION TOMOGRAPHY
Current state
PET allows assessment of speciﬁc metabolic functions with
tracers labelled with positron emitting radio-isotopes.
18Fludeoxyglucose (18FDG) is the most explored and estab-
lished PET tracer for in vivo imaging of atherosclerosis. 18FDG
PET can probe plaque inﬂammation in vulnerable plaques
directly. The disadvantage of PET is its limited spatial reso-
lution (3e5 mm), which makes anatomic assignment for FDG
Non-invasive Carotid Artery Imaging 569uptake imprecise. This can be partially offset by coregistra-
tion of the PET images with CT or MRI acquired by hybrid
scanner constructs, which are becoming more widely avail-
able (PET/CT and more recently PET/MRI). Non-speciﬁc up-
take of tracer by surrounding tissues (e.g. FDG uptake in
adjacent muscles and nodes) is also a hindrance.
Inﬂammation
A signiﬁcant correlation was found between the FDG PET
signal and macrophage staining from the corresponding
histologic sections in 17 patients with severe carotid ste-
nosis.57 Several studies have reported on the association
between FDG uptake and the risk of future events in both
asymptomatic and symptomatic individuals.57,58 Further-
more, in recently symptomatic carotid stenosis FDG uptake
in the ipsilateral carotid plaque was greater in patients with
early recurrent stroke.59
Plaque morphology
In 50 patients with symptomatic carotid stenosis the corre-
lation between plaque 18FDG standard uptake values and CT/
MRI ﬁndings (lipid rich necrotic core, vessel wall, and ﬁbrous
tissue volume) was weak.60 The correlations between CT and
MRI ﬁndings were moderate to strong. LRNC and calciﬁca-
tions were signiﬁcantly larger on CT, whereas measurements
of ﬁbrous tissue were signiﬁcantly larger on MRI.60 Plaque
calciﬁcation, which is generally suggested to confer stability
to the plaque, has also been found inversely related to PET
and histological biomarkers of inﬂammation.58
Discussion and future directions
PET has the advantage over existing imaging techniques to
target inﬂammation directly, using 18FDG as radioactive
tracer.57 Because of its limited spatial resolution, it lacks
anatomic precision and should therefore be combined with
CT or MRI images. It is however a versatile technique with
the potential to study other pathophysiological processes
underpinning plaque evolution directly.
Currently, other molecular PET tracers are being studied
in humans, for example 68Ga-labelled somatostatin receptor
probes as an alternative marker of inﬂammation and 18F-
sodium ﬂuoride potentially for microcalciﬁcation, with some
success. Tracers that probe lipid accumulation, proteolysis,
neoangionesis, and thrombosis are also potentially prom-
ising. However, data are limited and only available from
preclinical molecular imaging studies.61 To facilitate the
translation of promising PET tracers into the clinic setting,
the co-registration of PET images with CT or MRI is of
importance. Co-registration of MRI might be of additional
beneﬁt over CT as it better visualises the vessel wall.
Further information about molecular processes in the
carotid plaque can be obtained by use of single photon
emission computed tomography (SPECT). SPECT is similar to
PET in detecting gamma radiation, but has the disadvantage
of a two to three times lower spatial resolution. Radio-
labeled SPECT tracers that are available for speciﬁc plaque
vulnerability include 99mTc-labelled oxidised low-densitylipoprotein (99mTc-LDL) accumulation and apoptosis
(99mTc-annexin-V)62
DISCUSSION
The current review summarises the current state and more
importantly future directions in non-invasive imaging of
vulnerable carotid plaque. US, CT, MRI, and PET are non-
invasive imaging techniques that show promise for identi-
fying vulnerable plaque characteristics beyond the degree
of stenosis.
Although the aforementioned imaging parameters are
promising, at present there is no single imaging technique
that can clearly identify the vulnerable plaque. This is
because (a) there is no single imaging modality that can
detect all vulnerable plaque features, (b) plaque imaging is
expensive, time-consuming, and requires a reviewer with
advanced experience, and (c) prospective natural follow-up
studies analysing the value of these imaging modalities for
future cerebral events are limited. It is therefore important
to realise that even if we could reliable identify ulceration,
LRC, thin FC, and IPH as characteristics of the vulnerable
plaque, at this stage there is not enough evidence that
these patients indeed have a higher risk of stroke.
In order to provide more detailed morphological infor-
mation about the carotid plaque, the more established im-
aging techniques, such as US, CT, and MRI need to be further
improved. Furthermore, the development of functional mo-
lecular imaging techniques (PET and SPECT) and 3D US hold
promise for the future.29,57 In addition to the non-invasive
imaging techniques covered in this review, several invasive
techniques, such as optical coherence tomography, intra-
vascular ultrasound (IVUS), or combined IVUS with near
infrared spectroscopy, are areas of ongoing plaque imaging
research, but were beyond the scope of the current review.
Furthermore, due to the large amount of studies, it was not
feasible to report one parameter that describes the correla-
tion between plaque imaging techniques and histology.
Comparison of potential imaging characteristics of the
vulnerable plaque with histological analysis is essential to
further develop these future techniques. Application of
plaque imaging in ongoing or proposed prospective studies
and multicentre trials in patients with asymptomatic and
symptomatic carotid artery stenosis will tell us in the near
future if and how we can guide treatment on an individual
patient level.63e65
CONCLUSION
Currently available non-invasive imaging modalities for
atherosclerotic carotid plaque offer the potential to identify
speciﬁc vulnerable plaque components. MRI has the most
potential, with good sensitivity and speciﬁcity for most
plaque characteristics. However, currently there is no single
imaging modality that can reliably identify the vulnerable
plaque in relation to development of future stroke.
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Popliteal Vein Aneurysm
K. Spanos *, A.D. Giannoukas
Vascular Surgery Department, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, GreeceA 27-year-old female, 28 weeks pregnant (smoker with a previous caesarean section) presented with deteriorating left
lower limb pitting oedema over the previous 2 weeks without varicose veins and no history of trauma in the limb. A colour
ﬂow ultrasound scan revealed a popliteal vein aneurysm 33.5  31.1 mm (yellow arrow) without thrombus along with
dilated and incompetent superﬁcial femoral and popliteal veins, a likely cause of the progressive swelling. A prophylactic
dose of low-molecular-weight heparin and a knee-length elastic stocking were initiated for thromboembolic protection
during pregnancy and the post-partum period. Prospects for future deﬁnite treatment will be discussed with the patient.
